ATS Labs, Inc. Announces the Acquisition of MicroTest Labs, Inc.

Eagan, Minn., July 14, 2014 -- Today, ATS Labs, Inc. (ATS), majority owned by Ampersand Capital Partners, announced that it acquired the assets of MicroTest Labs, Inc. (MTL) of Agawam, MA.  The acquisition of MTL is the first step in the strategy of ATS to expand its microbiology and chemistry laboratory services platform to support the medical device and biopharmaceutical industries.  The combined companies will soon be known as Accuratus Lab Services, a name that personifies the quality and accuracy of testing results and scientific solutions that support the antimicrobial, consumer product, medical device, and biopharmaceutical industries.

“The acquisition of MicroTest by ATS has been a long time in the making and I could not be more pleased about the future of the two companies and how they will combine to create the market leader in providing microbiology and analytical chemistry testing services,” said Dr. Steve Richter, CEO of MTL.  Dr. Tom Burnell, Executive Chairman of ATS added, “Like ATS, MicroTest has a strong reputation in the industries it serves, which is supported by long-standing client relationships. Leveraging the strengths of the two companies will only further enhance our ability to continuously exceed our client’s expectations.”  It is expected that administrative functions will be consolidated, but the company will continue to operate at its locations in Eagan, MN and Agawam, MA.

About ATS Labs:

ATS Labs is the leading global provider of antimicrobial and biocide testing services; committed to improving public health and generating value for customers.  ATS Labs has been an expert partner to the developers, manufacturers, and users of antimicrobial products for over 20 years; providing a comprehensive range of microbiology, virology, and product chemistry services.

For more information on ATS Labs go to www.ATS-Labs.com.

About MicroTest Labs:

MicroTest Labs is a leader in testing services for the medical device, pharmaceutical and biotechnology industries.  Founded in 1984, the company’s expertise and flexible processes enhance product safety and security, speed time to market, and minimize supply chain disruption.

For more information on Microtest Labs go to www.MicroTestLabs.com.

About Ampersand Capital Partners:

Ampersand is a middle market private equity firm with a focus on growth equity investments in the Healthcare sector.  Over the past two decades, Ampersand has managed $1 billion in private equity partnerships.  Ampersand leverages its unique blend of private equity and operating experience to build value and drive superior long-term performance alongside its portfolio company management teams.  Ampersand’s portfolio has included more than 20 years of successful investments in the laboratory products and services industry.

Additional information about Ampersand is available at www.AmpersandCapital.com.

Download the official press release.